Scotia Capital’s CRH Medical Corporation CRHM Stock Holding History

Scotia Capital’s Portfolio CRHM Stock Details CRHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-16,100	Closed	-$131K	–	754
2017 Q1	$131K	Sell	16,100 -30,742	-66%	-$213K	﹤0.01%	697
2016 Q4	$249K	Buy	46,842 +25,842	+123%	+$131K	﹤0.01%	700
2016 Q3	$81K	Buy	21,000 +10,000	+91%	+$38.3K	﹤0.01%	754
2016 Q2	$43K	Buy	+11,000	New	+$36K	﹤0.01%	696
2016 Q1	–	Sell	-12,000	Closed	-$37K	–	886
2015 Q4	$37K	Hold	12,000	–	–	﹤0.01%	784
2015 Q3	$38K	Buy	+12,000	New	+$43.4K	﹤0.01%	758

Other funds holding CRHM

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

OSAM

O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $691M AUM 27.96% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

AII

AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return

Scotia Capital's CRHM Position: Q2 2017 in Review

Scotia Capital sold out of CRH Medical Corporation (CRHM) in Q2 2017, closing a stake of 16,100 shares — an estimated $131K sold.

Scotia Capital first reported a position in CRHM in Q3 2015 and held it in 6 quarters. The position peaked at $249K in Q4 2016. 59 funds tracked by Wall St. Rank hold CRHM as of Q2 2017.

Scotia Capital reported no remaining CRH Medical Corporation position as of Q2 2017 after selling out during the quarter.
Scotia Capital sold 16,100 CRH Medical Corporation shares in Q2 2017, an estimated $131K.
Scotia Capital first reported a position in CRH Medical Corporation in Q3 2015 and held it in 6 quarters.
Scotia Capital's CRH Medical Corporation position peaked at $249K in Q4 2016.
59 funds tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2017.

Based on Scotia Capital's 13F filing for Q2 2017, filed 15 Aug 2017.